HF

Hussain Fatepurwala

Director Director DIN 10146559
DIN 10146559 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2023
Shareholding value •••• Premium profile

About Hussain Fatepurwala

Data last updated:

Hussain Fatepurwala was a Director at Civanta Distributors Private Limited (2023–2024) and Director at Corogen Pharma Private Limited (2023–2024). The companies operate in Pharma.

DIN 10146559
Primary Designation Director
Industry Pharma
First Appointment 31 Jul 2023

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Civanta Distributors Private Limited U24231GJ1997PTC032843
Director15 Sep 20231997₹10.00 Cr (FY 2024)Active
Corogen Pharma Private Limited U28231GJ1997PTC032842
Director31 Jul 20231997₹9.76 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Civanta Distributors Private Limited
Corogen Pharma Private Limited
Premium access

Shareholding and investment profile for Hussain Fatepurwala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hussain Fatepurwala

Hussain Fatepurwala was first appointed on 31 Jul 2023 as Director at Corogen Pharma Private Limited.

Hussain Fatepurwala held 2 earlier board appointments: Civanta Distributors Private Limited (Director, 15 Sep 2023 to 31 May 2024); Corogen Pharma Private Limited (Director, 31 Jul 2023 to 31 May 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available